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Summary.-An in vitro agar colony technique has been developed for the growth
of tumour cells taken directly from human tumours grown in immune-suppressed
mice. The novel feature of the technique is the addition of a replenishable liquid
phase which permits the maintenance ofrelativelyslowly growing cells. A number of
different xenografted tumours have been cultured successfully in this system, with
red blood cells added to the agar and using 5% 02 in the gas phase.
The technique has been used to assay cell survival in tumours treated in vivo
with cytotoxic agents, and examples are given of survival curves obtained from a
pancreatic tumour irradiated with y-rays and a colonic tumour from mice treated
with cyclophosphamide.
The results obtained by this in vitro method are in agreement withthose from the
agar diffusion chamber technique.
This culture method has also been successfully used for the growth of cells taken
directly from human tumour biopsy samples obtained in the clinic.
THE development of xenografting
techniques, enabling human tumours to be
grown in immune-suppressed mice (as
shown for example by Castro, 1972, and
Cobb, 1973), has made it possible to
experiment in the laboratory on tumours
of human origin, and to study the effect
on them of the cytotoxic agents used in
cancer therapy.
Growth delay in subcutaneous tumours
has been widely studied as a measure of
tumour response. However, tumour size
after treatment is dependent on a number
of factors, and such measurements can
give only an indirect estimate of the pro-
portion of tumour cells killed. For some
experimentalanimaltumours, colonyassay
techniques have been used to obtain a
direct measure of surviving tumour cells
in the solid tumour, but they have not so
far been available for human cells.
This paper reports the development of
an in vitro colony assay technique that is a
modification of the soft agar method
devised for studying the growth of murine
tumour cells taken directly from mouse
tumours (Courtenay, 1976). Thistechnique
involved the use of a reduced 02 tension
and the addition of red blood cells which
had been shown by Bradley, Telfer and
Fry (1971) to enhance the growth of
mouse marrow. The use of soft agar for
the human tumours has been retained
since it has the advantage of providing
support for the cells, which frequently
have difficulty in attaching to the surface
of culture dishes and do not form discrete
colonies in monolayer culture. It also
discourages the growth of normal stromal
cells (Sanders and Burford, 1964) present
in cell suspensions obtained from the solid
tumours. Agar techniques are commonly
applied to rapidly dividing cells which
produce colonies of suitable size before
the available nutrients deteriorate or
become depleted. For more slowly grow-
ing cells this is a serious difficulty. One
solution to this problem is to grow theV. D. COURTENAY AND J. MILLS
cells in agar diffusion chambers implanted
in the mouse peritoneal cavity (Smith,
Courtenay and Gordon, 1976). This pro-
vides a practical method of measuring cell
survival, but it does require large numbers
of animals. In the present studies we have
developed an in vitro method suitable for
routine use in which tumnour cells are
suspended in soft agar that is allowed to
set in the rounded bottom of a test tube.
The compact hemispherical shape gives
considerable mechanical strength to the
agar and it is then relatively easy to add
liquid medium and change it as required.
The use of capped test tubes isolates the
individual cultures and prevents the
spread of moulds and fungi which can be a
problem in long-term culture in open
dishes. The results obtained with this
system have been compared with those
from diffusion chambers.
MATERIALS ANI) METHODS
HX32. The tumour designated HX32
was obtained in 1973 from a 34-year-old man
admitted to St Peter's Hospital, Chertsey.
The patient presented with extensive meta-
stases, the primary tumour apparently
originating from the pancreas. The patient
died of a pulmonary embolism a few hours
after the exploratory operation. A histological
section of the tumour from the patient is
shown in Fig. 1 together with the xenografted
tumour from Passage 11.
HX18. This tumour was derived from a
suture-line recurrence in a 61-year-old patient
following a hemicolectomy. The primary
tumour removed 20 months previously was a
poorly differentiated, mucin-secreting adeno-
carcinoma.
Both thie xenografts were originally ob-
tained by R. J. Pickard and HX18 was
used in cell kinetic studies reported by
Pickard, Cobb and Steel (1975).
Cell suspensions. Trumours were removed
under sterile conditions, rinsed in phosphate-
buffered saline (PBS) and chopped into
pieces of less than 1 mm diameter with
crossed scalpels. It was necessary to adapt
subsequent treatment to the requirements of
different tumours. FoI tumour HX32, the
pieces were incubated for 25 min at 37°C in
2 mg/ml collagenase (WTorthington) in culture
medium (Ham's F12 -with 15% Special
Bobby Calf Serum from Gibco-Biocult).
After 2 washes in PBS the pieces were incu-
bated for 5 min at 37°C in 0.05%0 trypsin
(Bacto trypsin, Difco) and the supernatant
decanted. The pieces were resuspended in
Ham's F12 without serum, and incubation
was continued for a further 3-5 min. The
container was then shaken x 3 to dislodge
cells from the pieces and, after the pieces
had settled, the cell suspension was removed
and serum added to a concentration of about
15% to stop the action of trypsin. The cells
were centrifuged for 3 min at less than
1000 rev/min, resuspended in culture medium
and then filtered through a 30 ,um polyester
mesh (Henry Simon, Stockport). After stand-
ing 15-20 min at 4°C (7 ml of medium in a
17 mm-diameter test tube) the top 2 of the
suspension w%Nas taken for use. Cells were
examined in a haemocytometer under phase
contrast and those that did not take up
lissamine green and had an intact and smooth
outline, were scored as viable.
For Tumour HX18, collagenase treatment
was not required. Trypsinization at 37°C was
continued for 20 min with a change to fresh
trypsin at 10 min. The suspension was
finally filtered through a 20 ,um mesh.
Heavily irradiated (HR) cells were pre-
pared from tumour cell suspensions exposed
to 10,000 rad y-rays from a 60Co source.
Red cells.-Blood was obtained by cardiac
puncture from August rats and the buffy
coat removed after centrifugation. The red
blood cells were rinsed x 3 by resuspending in
PBS and centrifuging, and finally made up
to the original volume with culture medium.
Aliquots not exceeding 10 ml were stored at
4°C in universal containers for periods up to 20
days. RBC used within 1 week were heated to
44°C for 1 h to destroy residual nucleatedcells.
Agar medium.-A 500 agar solution was
made by boiling powdered agar (Bacto agar,
Difco) in double-distilled water for 10 min.
After cooling to 44°C, 1 vol of 500 agar was
mixed with 9 vols of culture medium at 440C.
Culture procedure.-To set up a number of
replicate tubes, 1 vol of RBC suspension
diluted 1/4 plus 1 vol of HR tumour cells
(105/ml) was added to a test tube containing
2 vols of tumour cell suspension. After
wrarming to 37°C, 6 vols of 0500 agar at
44°C was added and mixed. Aliquots of 1 ml
were pipetted into individual tubes and
immediately plunged into crushed ice to set.
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FIG. 1.-Histological sections of the pancreatic tumour HX32. x 300. (a) Section of the original
tumour removed from the patient at the timne of operation. (b) Xenografted tumour at Passage
11. (c) Xenograft grown from cells maintained in culture for 24 months.V. D. COURTENAY AND J. MILLS
Fi'ro. l(C)
The tubes weregassedfor 5secusingamixture
of5% 02 and 90% N2 and 5% CO2 delivered
at 2 1/min via a Pasteur pipette, and the caps
were tightened. Gassing was repeated 20-
30 min later after the tubes had been warmed
to 37°C in a waterbath. The capped tubes
were not perfectly airtight and the gas
concentration was maintained by incubating
the tubes in (6 x 12 x 17 cm) transparent
polystyrene boxes (Stewart Plastics) gassed
with the same mixture via holes in opposite
sides of the box and finally sealed with
polythene adhesive tape. To check for gas
leaks, an indicator tube containing 1 ml
medium with phenol red indicator but with-
out serum was placed in each box. The tubes
were maintained in a vertical position and
incubated at 37°C.
After 5 days, when red cells had lysed, 2 ml
of medium was pipetted on top of the agar.
At 12 and 20 days the medium was changed;
the tubes being gassed on each occasion.
The boxes were gassed twice weekly.
After 28 days the agar was decanted on to a
slide, cut into 3 pieces and covered with a
(25 x 50 mm) coverslip. Colonies (>50 cells)
were counted using a magnification of x40.
RESULTS
Experiments on culture conditions
Fig. 2 shows the results ofmeasurements
with Tumour HX32 designed to test the
linearity of growth response over a range
of cell concentrations and under various
culture conditions. Groups of 5 replicate
tubes were set up by the standard pro-
cedure with RBC and with or without HR
cells. Tumour cells were added at a range
of concentrations and the tubes were
incubated with a gas phase containing
5% 02 + 5% C02 + 90% N2 with the
exception of 2 additional groups of tubes
in which the 02 concentration was in-
creased to 20%, the concentration in air.
With 5% 02 a plating efficiency (PE) of
,30°% was obtained over the range
25-500 cells per tube, demonstrating
linearity between colony number and the
number of cells plated out. However, the
addition of 104 HR cells increased PE to
42%. Consequently, for survival experi-
ments, HR cells were added as a standard
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FIG. 2. Plating efficiency plotted against
number of tumour cells plated, using a gas
phase containing 5 or 20%02- 0, 5% 02
with 104 HR cells; x, 5% 02 without HR
cells; A, 20% 02 without HR cells.
procedure to bring the total number of
cells to 104 per tube.
Colonies were also obtained in tubes
gassed with 20% 02 but the PE was
only 20% and the colonies tended to be
rather smaller. This result shows that
the lower 02 tension of 5°O gave a useful
increase in PE and slightly improved cell
growth, but to a smaller extent than
previously found for the Lewis lung
tumour.
Rat RBC, previously shown to enhance
the growth of mouse tumours, were
similarly effective with tumour HX32,
and results showing that RBCs gave a
3-fold increase in PE are given in Table I.
The growth factor in RBC is released only
after cell lysis, which occurs over a period
of 5-7 days under our culture conditions,
thus making the growth factor available
at the critical time when colony growth is
initiated. Blood from August rats was
much superior to that from Wistar and
Marshall rats, whose RBCs fail to lyse
within the first week of culture. The
addition of lysates instead of whole RBC
was also found to be less effective, due to
the instability of the growth factor after
release from the RBC. Probably for the
same reason, RBC added to the liquid
phase instead ofto the agar failed to give a
good PE, suggesting that the growth
factor was broken down before there was
time for it to diffuse through the agar.
The results in Table I demonstrate the
effect oftwo different RBC concentrations
on PE, using RBC stored forup to 16 days.
Each tube was seeded with 500 tumour
cells without adding HR cells and RBC
were obtained from 3 different batches of
blood taken 2, 7 and 16 days previously.
The 2- and 7-day RBCs, but not the 16-day
RBCs, were heat-treated to destroy the
nucleated cells. The results show no
deterioration in the PE of blood stored for
up to 16 days. In separate experiments
with RBCs stored for 3 weeks or more,
appreciable lysis was observed and such
lysed RBCs wereless effective in promoting
cell growth.
The results obtained using a RBC
dilution of 1/2 and 1/4 showed no differ-
ence between the 2 dilutions. The 1/2
dilution had previously been used for the
growth of mouse tumour cells but on the
basis of these results the 1/4 dilution
has been adopted for the standard proce-
dure.
There were indications, in preliminary
experiments, that after 10-14 days in
culture toxic substances were produced,
possibly from the breakdown of released
haemoglobin which at this stage was
brown in colour. However, the addition of
culture medium above the agar, in the
standard procedure, dilutes the toxic
products to a harmless level.
TABLE I. Effect of RBC on Plating Efficiency of HX32
Storage time
(days) Treatment
2 Heated
2 Heated
7 Heated
7 Heated
16 Unheated
1 6 Unheated
No blood a(lde(l
>>
c
a)
0)
0~
18
RBC dilution
1/2
1/4
1/2
1/4
1/2
1/4
PE (%)
24-7 ± 1-6
20-1 ± 0.5
25-6 ± 07
26-6 ± 1-5
28-4 ± 1 9
26-0 ± 0-8
95 + 09
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TABLE II. Plating Efficiencies Obtained from Various Xenografted Turmours
No. of
tumours
Total w!ith PE
Tumourl type examined >0.1%
Colorectal
Oat-cell Ca
Pancreatic
*MIelanoma
*Uterine
Teratoma
2
1
1
1
6
2
2
(
0
PE (%)
0.1
1*9
1-4
0.4
0 3
04
0'3
3 0
30-50
\3-0
8-12
98
Growth
period
Tumour line weeks
5
4
HXIS 4
4
HX29 4
H-fX3:3 4
HX32 4
4
HX:34 5
HX35 3
* Grown in culture before passaging in mice.
The culture technique has now been
applied to the growth of a number of
other xenografted tumours, and a second
pancreatic tumour has given colonies with
a PE of 30 (Table II). Colorectal tumours
grow less well, and out of 12 tumours
tested, only 6 gave colonies in agar, with
PE of 01 to 199%. Colonies were also
obtained from 2 of 3 oat-cell carcinomas of
the lung. These tumours gave suspensions
without the use of enzymes. However, the
single cells were fragile and many lost the
ability to exclude lissamine green within
2 h after the preparation of cell suspen-
sions. The low PE obtained could there-
fore have been due to the high proportion
ofdamaged ordying cells in thesuspension.
Two other xenografted tumours, a
uterine adenocarcinoma and a spindle-cell
melanoma gave higher PE, of about
10%. Both of these tumours had been
maintained in culture before implantation
into immune-suppressed mice. The mela-
noma was derived from a biopsy specimen
obtained in the clinic and grown in
monolayer culture for 2 months before
passaging in the mouse. In the xenograft,
the characteristic morphology of the cells
was retained and melanosomes were
identified in the cytoplasm by electron
microscopy.
The uterine tumour was obtained as a
metastasis from a 74-year-old woman
from whom an adenocarcinoma of the
uterus had been removed 8 years previous-
ly. A cell suspension from the tumour
removed at surgery was prepared and
plated out by the standard method in
agar. From a cell concentration of 1 04
per tube, colonies were obtained with a
PE of 12U. Some of the colonies were
picked out and used to establish a mono-
layer culture which was subsequently
passaged into immune-suppressed mice.
The PE of cells from the xenograft was
9*8%o comparable to that of the cells
taken directly from the original biopsy
specimen.
Colonies have also been obtained from
a number of other tumours obtained as
biopsy specimens in the clinic and the
results will be reported elsewhere.
In order to establish whether the
xenografts had retained their human
chromosome complement, chromosome
preparations were made from cell sus-
pensions prepared from the solid tumour
in all the xenografts used in these studies.
It was found that the cells had retained a
human karyotype, with acrocentric and
metacentric chromosomes. A minority of
cells (less than 1%) possessed only the
telocentric chromosomes typical of mouse
cells, and these were taken to represent
mouse-derived stromal cells. There was
no evidence of hybridization between
human and mouse cells. After 16 days in
monolayer culture, cells of Tumours
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HX18 and HX32 showed no mouse
chromosomes in over 200 metaphase
spreads counted. Cultures seeded from
agar colonies were morphologically similar
to those grown in monolayer culture
directly from the mouse. Conclusive evi-
dence that the cells growing in culture
were tumour cells and representative of
those in the xenograft was first obtained
for the HX18 tumour. After 2 months
growth in culture, 5 X 105 HX18 cells
were injected s.c. into each of 20 mice, and
in 5 of the mice tumours were produced
at the site of injection. On microscopic
examination these were indistinguishable
from the original xenograft. A similar
result was obtained from cultured HX32
cells implanted into mice. Fig. 1 shows a
histological section of this tumour for
comparison with the regularly passaged
HX32 tumour and they can be seen to be
closely similar.
Application of the in vitro agar assay
The assay technique has been applied
to the measurement of cell survival in
solid tumours treated with various
toxic agents. As an example, a radi
survival curve for the HX32 ti
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FIG. 3.-Cell-survival curve for Tumc
HX32 treated in the mouse with y-rays.
exposed to y-rays is shown in Fig. 3.
The tumours were irradiated in situ in
the mouse and removed for assay 18h
later. A number of different cell dilutions
were set up in agar, and from the colony
countthesurvivingfraction was calculated
by dividing the PE by that of the un-
treated controls. The points shown on the
curve were obtained in 7 different experi-
ments and they give an indication of the
reproducibility of the technique.
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FIG. 4.-Cell-survival curve for Tumour
HX18 treated in the mouse with cyclo-
phosphamide and assayed by the agar
diffusion chamber technique in parallel
with the in vitro assay. 0, in vitro assay;
A, agar diffusion chamber assay.
cyto-I Fig. 4 shows a cell-survival curve for the iation- colonic tumour HX18 treated in vivo
timour with cyclophosphamide. The drug was
injected i.p. into tumour-bearing mice in
single doses of un to 300 mv/ka. the
maximum tolerated dose, and the tumours
were removed 18 h later and cell sus-
pensions prepared for assay. At the same
time a parallel assay was carried out
using the agar diffusion chamber method
(Smith, Courtenay and Gordon, 1976).
With this technique, tumour cells are
suspended in agar in diffusion chambers
which are implanted into the peritoneal
cavity of previously irradiated mice. The
chambers are incubated within the mouse
for about 3 weeks, during which time
nutrient substances in the peritoneal
fluid are able to reach the tumour cells by
diffusion. Cell survival values obtained
by the 2 methods were comnarable. and
10 _. _--
- -__ WLA% 1500 it was concluded that the more artificial
growth conditions of the in vitro assay
:ur did not influence the recovery ofthe drug- treated cells.
E-~~~~~~~~~~~~~~~~~~~~~~~~~~~~
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DISCUSSION AND CONCLUSIONS
The agar colony technique we have
developed has been designed for the
growth of relatively slowly proliferating
tumour cells by using a replenishable
liquid phase above the agar which permits
continued growth throughout the 4 or
more weeks necessary for the production
of colonies of suitable size. The addition
to the agar of rat RBC, which lyse and
release a labile growth factor available
to the growing cells, consistently improved
the PE of cells from a number of different
human tumour xenografts. The require-
ment for the growth factor may well be a
characteristic of cells in primary culture,
since RBC also enhance the growth of
marrow, and also of Lewis lung and
B16 mouse tumour cells taken directly
from the animal.
Ofthe 20 different xenografted tumours
studied, 12 gave rise to colonies in agar.
However, considerable differences in PE
were observed for different tumours. The
majority of tumours tested were of
colorectal origin, and half of these gave
colonies in agar, but the PE was low
(<2%). This could be because the pro-
portion of clonogenic cells in the tumour
was small, or because of some special
metabolic requirement of these cells. It
could also be associated with cellular
damage sustained in the preparation of
the cell suspension and the higher PE
of i10% obtained from a melanoma and
a uterine tumour, which yielded cell
suspensions without the use of enzymes,
supports this possibility.
The pancreatic tumour HX32 which
gave the highest PE (averaging 30%) is
particularly suitable for experimental use
and has been the subject of further
radiation studies (Courtenay et al., 1976;
Smith, Courtenay and Steel, 1978).
Some of the other tumours studied here
have also been used to measure clonogenic
cell survival after treatment with cyto-
toxic agents. The agreement between the
results obtained in parallel experiments
on the colonic tumour HX18 using agar
diffusion chambers implanted in the
mouse and the in vitro agar method has
provided additional evidence of the valid-
ity of the in vitro assay.
The successful growth of colonies from a
tumour taken directly from a patient has
also demonstrated the application of the
culture technique for the growth of cells
taken directly from human biopsy
material, and the method has now been
used to grow colonies from a number of
other tumours obtained in the clinic (in
preparation).
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